Relationship of Serum Transferrin Levels to Overall Survival in Cancer Patients: Findings from a Multi-Center Cohort Analysis - Top-Institutions - MDSpire

Relationship of Serum Transferrin Levels to Overall Survival in Cancer Patients: Findings from a Multi-Center Cohort Analysis

  • By

  • Qianqian Zhao

  • Kai Sun

  • Xiaoxiao Wu

  • Fangqi Shen

  • Xi Chen

  • Chunhua Song

  • Xiaolin Wang

  • Hongxia Xu

  • Minghua Cong

  • Hanping Shi

  • Pingping Jia

  • January 26, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Cancer Research
    • Clinical Nutrition

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Hematology
    • Cancer Biology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Cancer Nutrition
    • Translational Medicine

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Hematology
    • Clinical Nutrition

  • #5

    Peking University Cancer Hospital & Institute
    Peking University Cancer Hospital & Institute

    Beijing, Beijing

    Key Differentiators

    • Oncology
    • Cancer Epidemiology
    • Clinical Nutrition

Original Source(s)

Relationship of Serum Transferrin Levels to Overall Survival in Cancer Patients: Findings from a Multi-Center Cohort Analysis

  • by Qianqian Zhao, Kai Sun, Xiaoxiao Wu, Fangqi Shen, Xi Chen, Chunhua Song, Xiaolin Wang, Hongxia Xu, Minghua Cong, Hanping Shi, Pingping Jia

  • January 26, 2026

Related Content

Scanning New Horizons (in Digital Pathology)

How biomedical imaging technician Andrew Mullen championed the implementation of digital pathology across a large children's hospital

  • April 3, 2026

  • 5 min
Ocular Adverse Effects Linked to Antibody-Drug Conjugates in Cancer Treatment: An In-Depth Analysis

The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001-P909)

  • November 5, 2025